Archives for September 28, 2008

← 2008

PEPFAR drops Ranbaxy from recommended list

By Gareth Macdonald

Ranbaxy’s antiretrovirals zidovudine, lamivudine, and nevirapine have been removed from PEPFAR’s list of approved products until ongoing GMP problems at two of the firm’s Indian manufacturing plants are resolved.